Prevention

Ogata T et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4106-2

Quesada-Gomez JM, Bouillon R. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4520-y

Wong EKC, Papaioannou A. Curr Treat Options in Rheum 2018; Advance online publication. doi: 10.1007/s40674-018-0098-y

This guideline, accredited by the National Institute of Health and Care Excellence, provides an overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.

Compston J, Cooper A, Cooper C et al. Arch Osteoporos 2017;12:43. doi:10.1007/s11657-017-0324-5

Alonso N, Calero-Paniagua I, del Pino-Montes J. Clinic Rev Bone Miner Metab 2017; 15: 37. doi: 10.1007/s12018-016-9226-0

This chapter describes the non-pharmacological approaches to the prevention of falls and fall-related injuries in older people, and emphasises effective strategies in a range of population groups.

Lord SR, Close JCT, Sherrington C. In: Osteoporosis in Older Persons. Edited by Duque G, Kile DP. Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-25976-5_12

An expert review of the manifestations of osteoporosis in childhood, recommendations for monitoring and prevention, and suggestions for when a child should be considered a candidate for therapy.

Ward LM, Konji VN, & Ma J. Osteoporos Int 2016;27:2147–2179. doi:10.1007/s00198-016-3515-9

Lin and Grossman highlight a number of recommendations for the prevention and treatment of comorbid bone disease in systemic lupus erythematosus patients.

Lin T & Grossman J. Curr Treat Options in Rheum 2016;2:21–35. doi:10.1007/s40674-016-0034-y

This review discusses the main heritable and non-heritable factors that contribute to the pathogenesis of primary osteoporosis, focusing on the genetic and epigenetic basis of polygenic osteoporosis.

Nat Rev Rheumatol 2015;11:462–474. doi:10.1038/nrrheum.2015.48